Onderneming Corvus Pharmaceuticals, Inc.
Aandelen
CRVS
US2210151005
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,454 USD | -3,68% | +2,84% | -17,61% |
Vakgebied
Aantal werknemers: 28
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27-01-14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | - | 06/02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Ian Clark
BRD | Director/Board Member | 62 | 03-01-17 |
Terry Gould
BRD | Director/Board Member | 67 | 01-11-14 |
Peter Thompson
FOU | Founder | 64 | 27-01-14 |
Linda Grais
BRD | Director/Board Member | 68 | 28-01-19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01-12-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 49 038 582 | 43 856 630 ( 89,43 %) | 0 | 89,43 % |
Bedrijfsgegevens
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,61% | 74,05 mln. | |
+1,51% | 43,84 mld. | |
+6,16% | 41,68 mld. | |
+45,04% | 41,25 mld. | |
-10,92% | 27,04 mld. | |
+7,21% | 25,53 mld. | |
-25,55% | 18,18 mld. | |
-1,86% | 12,29 mld. | |
+25,61% | 12,29 mld. | |
+6,86% | 11,15 mld. |
- Beurs
- Aandelen
- Koers CRVS
- Onderneming Corvus Pharmaceuticals, Inc.